Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common stock and additional paid-in capital	Treasury Stock	Accumulated other comprehensive loss	Retained earnings
Beginning balance at Dec. 31, 2020	$ 11,065,240	$ 3,447,698	$ 0	$ 44,398	$ 7,573,144
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		100,942
Stock-based compensation expense		303,891
Repurchases of common stock to be held as treasury stock			(600,022)
Other comprehensive loss				(64,233)
Net income	4,508,799				4,508,799
Ending balance at Sep. 30, 2021	15,314,617	3,852,531	(600,022)	(19,835)	12,081,943
Beginning balance at Jun. 30, 2021	13,863,871	3,721,246	(500,022)	9,775	10,632,872
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		36,207
Stock-based compensation expense		95,078
Repurchases of common stock to be held as treasury stock			(100,000)
Other comprehensive loss				(29,610)
Net income	1,449,071				1,449,071
Ending balance at Sep. 30, 2021	15,314,617	3,852,531	(600,022)	(19,835)	12,081,943
Beginning balance at Dec. 31, 2021	15,849,248	4,024,561	(824,190)	(40,495)	12,689,372
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		27,738
Stock-based compensation expense		421,663
Other comprehensive loss				(207,148)
Net income	4,436,640				4,436,640
Ending balance at Sep. 30, 2022	20,528,141	4,473,962	(824,190)	(247,643)	17,126,012
Beginning balance at Jun. 30, 2022	19,075,974	4,316,870	(824,190)	(144,476)	15,727,770
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options		5,030
Stock-based compensation expense		152,062
Other comprehensive loss				(103,167)
Net income	1,398,242				1,398,242
Ending balance at Sep. 30, 2022	$ 20,528,141	$ 4,473,962	$ (824,190)	$ (247,643)	$ 17,126,012